trastuzumab deruxtecan doubles pfs in metastatic breast cancer with low her2 expression
Published 2 years ago • 713 plays • Length 5:40Download video MP4
Download video MP3
Similar videos
-
3:06
trastuzumab deruxtecan effective against brain metastases in her2-positive breast cancer
-
2:12
trastuzumab deruxtecan in her2-low advanced breast cancer | nejm
-
4:03
trastuzumab deruxtecan significantly improves pfs in breast cancer patients previously treated w...
-
5:26
trastuzumab deruxtecan shows benefit in patients with her2 mbc
-
1:05
efficacy of trastuzumab deruxtecan in her2-low metastatic breast cancer
-
5:09
trastuzumab deruxtecan shows benefit across her2 metastatic breast cancer subgroups
-
3:31
her2-low mbc patients report preserved qol with trastuzumab deruxtecan
-
0:57
enhertu - what it is and how it works #breastcancer
-
7:13
overview of the management of her2-low breast cancer patients
-
4:01
trastuzumab deruxtecan: a promising agent for treating her2-low breast cancer?
-
1:16
her2-low expression in breast cancer
-
12:47
trastuzumab deruxtecan vs trastuzumab emtansine in patients with her2 metastatic breast cancer
-
5:57
phase 3 study shows her2 therapy clinically meaningful for metastatic breast cancer patients
-
1:17
clinical outcomes in women with metastatic her2-low breast cancer in the real world
-
2:01
destiny-breast04: practice-changing results for her2-low breast cancer
-
0:56
remaining questions on the management of her2-low breast cancer
-
1:17
comment: phase 3 study shows her2 therapy clinically meaningful for metastatic breast cancer pts
-
3:05
trastuzumab deruxtecan gives strong anti-tumour activity in multiple tumour types
-
0:56
destiny-breast04: t-dxd for patients with her2-low mbc